614 related articles for article (PubMed ID: 32671117)
21. Immune Profile Analysis in Peripheral Blood and Tumor in Patients with Malignant Melanoma.
Saito R; Sawada Y; Nakamura M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669410
[TBL] [Abstract][Full Text] [Related]
22. Normalization Cancer Immunotherapy for Melanoma.
Vesely MD; Chen L
J Invest Dermatol; 2020 Jun; 140(6):1134-1142. PubMed ID: 32092349
[TBL] [Abstract][Full Text] [Related]
23. No longer an untreatable disease: how targeted and immunotherapies have changed the management of melanoma patients.
Girotti MR; Saturno G; Lorigan P; Marais R
Mol Oncol; 2014 Sep; 8(6):1140-58. PubMed ID: 25178978
[TBL] [Abstract][Full Text] [Related]
24. New drug targets in metastatic melanoma.
Homet B; Ribas A
J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
[TBL] [Abstract][Full Text] [Related]
25. The Immunology of Melanoma.
Ko JS
Clin Lab Med; 2017 Sep; 37(3):449-471. PubMed ID: 28802495
[TBL] [Abstract][Full Text] [Related]
26. Immune Responses to BRAF-Targeted Therapy in Melanoma: Is Targeted Therapy Immunotherapy?
Kelley MC
Crit Rev Oncog; 2016; 21(1-2):83-91. PubMed ID: 27481005
[TBL] [Abstract][Full Text] [Related]
27. Melanoma immunotherapy: strategies to overcome pharmacological resistance.
Trojaniello C; Vitale MG; Scarpato L; Esposito A; Ascierto PA
Expert Rev Anticancer Ther; 2020 Apr; 20(4):289-304. PubMed ID: 32195606
[No Abstract] [Full Text] [Related]
28. Kinase inhibitors and immune check-point blockade for the treatment of metastatic melanoma and advanced cancer: synergistic or antagonistic?
Luke JJ; Ott PA
Expert Opin Pharmacother; 2013 Dec; 14(18):2457-62. PubMed ID: 24138302
[TBL] [Abstract][Full Text] [Related]
29. A role of immunotherapy in metastatic malignant melanoma.
Allen T; Gundrajakuppam L
Cent Nerv Syst Agents Med Chem; 2012 Sep; 12(3):182-8. PubMed ID: 22697295
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy for Melanoma.
Albittar AA; Alhalabi O; Glitza Oliva IC
Adv Exp Med Biol; 2020; 1244():51-68. PubMed ID: 32301010
[TBL] [Abstract][Full Text] [Related]
31. The potential of BRAF-targeted therapy combined with immunotherapy in melanoma.
Naderi-Azad S; Sullivan R
Expert Rev Anticancer Ther; 2020 Feb; 20(2):131-136. PubMed ID: 32003263
[No Abstract] [Full Text] [Related]
32. Systemic Therapy Options for Patients With Unresectable Melanoma.
Yushak M; Chapman P; Robert C; Kudchadkar R
Am Soc Clin Oncol Educ Book; 2017; 37():661-672. PubMed ID: 28561662
[TBL] [Abstract][Full Text] [Related]
33. Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors.
Gentzler R; Hall R; Kunk PR; Gaughan E; Dillon P; Slingluff CL; Rahma OE
Immunotherapy; 2016 May; 8(5):583-600. PubMed ID: 27140411
[TBL] [Abstract][Full Text] [Related]
34. Combinatorial approach to treatment of melanoma.
Ashworth MT; Daud AI
Hematol Oncol Clin North Am; 2014 Jun; 28(3):601-12. PubMed ID: 24880950
[TBL] [Abstract][Full Text] [Related]
35. [Advances in immunotherapy for metastatic melanoma].
Oláh J
Magy Onkol; 2017 Jun; 61(2):132-136. PubMed ID: 28585614
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous melanoma and the immunotherapy revolution (Review).
Leonardi GC; Candido S; Falzone L; Spandidos DA; Libra M
Int J Oncol; 2020 Sep; 57(3):609-618. PubMed ID: 32582963
[TBL] [Abstract][Full Text] [Related]
37. T cell receptor therapy against melanoma-Immunotherapy for the future?
Winge-Main AK; Wälchli S; Inderberg EM
Scand J Immunol; 2020 Oct; 92(4):e12927. PubMed ID: 32640053
[TBL] [Abstract][Full Text] [Related]
38. Role of Surgery in Combination with Immunotherapy.
Klemen ND; Shindorf ML; Sherry RM
Surg Oncol Clin N Am; 2019 Jul; 28(3):481-487. PubMed ID: 31079801
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?
Schummer P; Schilling B; Gesierich A
Am J Clin Dermatol; 2020 Aug; 21(4):493-504. PubMed ID: 32124332
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy for advanced melanoma: fulfilling the promise.
Gogas H; Polyzos A; Kirkwood J
Cancer Treat Rev; 2013 Dec; 39(8):879-85. PubMed ID: 23725878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]